{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T07:31:13Z","timestamp":1767598273523,"version":"3.33.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-10480-x","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T19:54:02Z","timestamp":1738007642000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The evolving landscape of COVID-19: factors associated with in-hospital COVID-19 related mortality during the 2023\u20132024 phase of JN.1 subvariant dominance"],"prefix":"10.1186","volume":"25","author":[{"given":"Drieda","family":"Za\u00e7e","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albiana","family":"\u00c7ekrezi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludovica","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"De Simone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Teti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Malagnino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Iannetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loredana","family":"Sarmati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Maria","family":"Geretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,27]]},"reference":[{"key":"10480_CR1","unstructured":"World Health Organization. WHO-COVID19 dashboard. Available at: https:\/\/data.who.int\/dashboards\/covid19 (accessed Dec 2024)."},{"key":"10480_CR2","doi-asserted-by":"publisher","first-page":"1342917","DOI":"10.3389\/fepid.2024.1342917","volume":"4","author":"LP Roser","year":"2024","unstructured":"Roser LP, Samanapally H, Ali T, et al. Different clinical characteristics and outcomes of adult hhospitalisedSARS-CoV-2 pneumonia patients complicated by cardiovascular events during the first, delta and omicron waves of COVID-19. Front Epidemiol. 2024;4:1342917.","journal-title":"Front Epidemiol"},{"key":"10480_CR3","unstructured":"Centers for Disease Control and Prevention (CDC). COVID Data Tracker. Available at: https:\/\/covid.cdc.gov\/covid-data-tracker\/#variant-summary (accessed Dec 2024)."},{"key":"10480_CR4","doi-asserted-by":"publisher","first-page":"8550","DOI":"10.1038\/s41467-024-52668-w","volume":"15","author":"JA Lewnard","year":"2024","unstructured":"Lewnard JA, Mahale P, Malden D, et al. Immune escape and attenuated severity associated with the SARS-CoV-2 BA.2.86\/JN.1 lineage. Nat Commun. 2024;15:8550.","journal-title":"Nat Commun"},{"key":"10480_CR5","unstructured":"Istituto Superiore di Sanit\u00e0. COVID-19 integrated surveillance: key national data. Available at: https:\/\/www.epicentro.iss.it\/en\/coronavirus\/sars-cov-2-integrated-surveillance-data (accessed Dec 2024)."},{"key":"10480_CR6","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s12016-022-08921-5","volume":"64","author":"JJ Zhang","year":"2023","unstructured":"Zhang JJ, Dong X, Liu GH, Gao YD. Risk and protective factors for COVID-19 morbidity, severity, and mortality. Clin Rev Allergy Immunol. 2023;64:90\u2013107.","journal-title":"Clin Rev Allergy Immunol"},{"key":"10480_CR7","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.1017\/S0950268824000633","volume":"152","author":"JO Park","year":"2024","unstructured":"Park JO, Cho HK, Jeon CH, et al. Characteristics and biomarkers associated with mortality in COVID-19 patients presenting to the emergency department. Epidemiol Infect. 2024;152:e76.","journal-title":"Epidemiol Infect"},{"key":"10480_CR8","doi-asserted-by":"publisher","first-page":"e29591","DOI":"10.1016\/j.heliyon.2024.e29591","volume":"10","author":"BW Citarella","year":"2024","unstructured":"Citarella BW, Kartsonaki C, Ib\u00e1\u00f1ez-Prada ED. Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms. Heliyon. 2024;10:e29591.","journal-title":"Heliyon"},{"key":"10480_CR9","doi-asserted-by":"publisher","first-page":"e069761","DOI":"10.1136\/bmj-2021-069761","volume":"376","author":"AS Lauring","year":"2022","unstructured":"Lauring AS, Tenforde MW, Chappell JD, et al. Clinical severity of, and effectiveness of mRNA vaccines against, COVID-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study. BMJ. 2022;376:e069761.","journal-title":"BMJ"},{"key":"10480_CR10","unstructured":"Ministry of Health. COVID-19. Available at: https:\/\/www.salute.gov.it\/portale\/nuovocoronavirus\/archivioNormativaNuovoCoronavirus.jsp and https:\/\/www.salute.gov.it\/reportVacciniAntiCovid\/ (accessed Dec 2024)."},{"key":"10480_CR11","unstructured":"Istituto Superiore di Sanit\u00e0. Vaccines & immunisations. Available at: https:\/\/www.epicentro.iss.it\/en\/vaccines\/ (accessed Dec 2024)."},{"key":"10480_CR12","doi-asserted-by":"publisher","first-page":"126026","DOI":"10.1016\/j.vaccine.2024.05.074","volume":"42","author":"M Fabiani","year":"2024","unstructured":"Fabiani M, Mateo-Urdiales A, Sacco C, et al. Effectiveness against severe COVID-19 of a seasonal booster dose of bivalent (original\/Omicron BA.4\u20135) mRNA vaccines in persons aged\u2009\u2265\u200960 years: estimates over calendar time and by time since administration during prevalent circulation of different Omicron subvariants, Italy, 2022\u20132023. Vaccine. 2024;42:126026.","journal-title":"Vaccine"},{"key":"10480_CR13","unstructured":"Lelo K, Monni S, Tomassi F. Dec Roma, tra centro e periferie: Come incidono le dinamiche urbanistiche sulle disuguaglianze socio-economiche. Available at: https:\/\/www.academia.edu\/28425463\/Roma_tra_centro_e_periferie_come_incidono_le_dinamiche_urbanistiche_sulle_disuguaglianze_socio_economiche (accessed 2024)."},{"key":"10480_CR14","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.7326\/ANNALS-24-00464","volume":"177","author":"RM Gulick","year":"2024","unstructured":"Gulick RM, Pau AK, Daar E, et al. National Institutes of Health COVID-19 treatment guidelines panel: perspectives and lessons learned. Ann Intern Med. 2024;177:1547\u201357.","journal-title":"Ann Intern Med"},{"key":"10480_CR15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373\u201383.","journal-title":"J Chronic Dis"},{"key":"10480_CR16","doi-asserted-by":"publisher","first-page":"12762","DOI":"10.1038\/s41598-021-90983-0","volume":"11","author":"M Iannetta","year":"2021","unstructured":"Iannetta M, Buccisano F, Fraboni D, et al. Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in SARS-CoV-2 infected patients: a single center study. Sci Rep. 2021;11:12762.","journal-title":"Sci Rep"},{"key":"10480_CR17","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1001\/jama.2024.7395","volume":"331","author":"Y Xie","year":"2024","unstructured":"Xie Y, Choi T, Al-Aly Z. Mortality in patients hospitalised for COVID-19 vs influenza in fall-winter 2023\u20132024. JAMA. 2024;331:1963\u20135.","journal-title":"JAMA"},{"key":"10480_CR18","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/S1473-3099(24)00353-0","volume":"24","author":"MH Choi","year":"2024","unstructured":"Choi MH, Wan EYF, Wong ICK, et al. Comparative effectiveness of combination therapy with nirmatrelvir-ritonavir and remdesivir versus monotherapy with remdesivir or nirmatrelvir-ritonavir in patients hospitalised with COVID-19: a target trial emulation study. Lancet Infect Dis. 2024;24:1213\u201324.","journal-title":"Lancet Infect Dis"},{"key":"10480_CR19","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1007\/s15010-024-02245-6","volume":"52","author":"M Drysdale","year":"2024","unstructured":"Drysdale M, Berktas M, Gibbons DC, Rolland C, Lavoie L, Lloyd EJ. Real-world effectiveness of sotrovimab for the treatment of SARS-CoV-2 infection during Omicron BA.2 and BA.5 subvariant predominance: a systematic literature review. Infection. 2024;52:1839\u201361.","journal-title":"Infection"},{"key":"10480_CR20","doi-asserted-by":"publisher","first-page":"e0304822","DOI":"10.1371\/journal.pone.0304822","volume":"19","author":"CF Bell","year":"2024","unstructured":"Bell CF, Gibbons DC, Drysdale M, et al. Real-world effectiveness of sotrovimab in preventing hospitalisation and mortality in high-risk patients with COVID-19 in the United States: a cohort study from the Mayo Clinic electronic health records. PLoS ONE. 2024;19:e0304822.","journal-title":"PLoS ONE"},{"key":"10480_CR21","first-page":"1","volume":"11","author":"S Rajme-L\u00f3pez","year":"2024","unstructured":"Rajme-L\u00f3pez S, Martinez-Guerra BA, Rom\u00e1n-Montes CM, et al. Nirmatrelvir\/ritonavir and remdesivir against symptomatic treatment in high-risk COVID-19 outpatients to prevent hhospitalisationor death during the Omicron era: a propensity score-matched study. Ther Adv Infect Dis. 2024;11:1\u20138.","journal-title":"Ther Adv Infect Dis"},{"key":"10480_CR22","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1093\/cid\/ciad685","volume":"78","author":"EA Meyerowitz","year":"2024","unstructured":"Meyerowitz EA, Li Y. The landscape of antiviral therapy for COVID-19 in the era of widespread population immunity and omicron-lineage viruses. Clin Infect Dis. 2024;78:908\u201317.","journal-title":"Clin Infect Dis"},{"key":"10480_CR23","doi-asserted-by":"publisher","first-page":"107095","DOI":"10.1016\/j.ijantimicag.2024.107095","volume":"63","author":"J Calder\u00f3n-Parra","year":"2024","unstructured":"Calder\u00f3n-Parra J, Guti\u00e9rrez-Villanueva A, Ronda-Roca G, et al. Efficacy and safety of antiviral plus anti-spike monoclonal antibody combination therapy vs. monotherapy for high-risk immunocompromised patients with mild-to-moderate SARS-CoV2 infection during the Omicron era. A prospective cohort study. Int J Antimicrob Agents. 2024;63:107095.","journal-title":"Int J Antimicrob Agents"},{"key":"10480_CR24","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1186\/s12879-024-09466-y","volume":"24","author":"S Rotundo","year":"2024","unstructured":"Rotundo S, Berardelli L, Gull\u00ec S, et al. Early initiation of combined therapy in severely immunocompromised patients with COVID-19: a retrospective cohort study. BMC Infect Dis. 2024;24:564.","journal-title":"BMC Infect Dis"},{"key":"10480_CR25","doi-asserted-by":"publisher","first-page":"e14301","DOI":"10.1111\/tid.14301","volume":"26","author":"PM Kinsella","year":"2024","unstructured":"Kinsella PM, Moso MA, Morrissey CO, Dendle C, Guy S, Bond K, et al. Antiviral therapies for the management of persistent coronavirus disease 2019 in immunocompromised hosts: a narrative review. Transpl Infect Dis. 2024;26:e14301.","journal-title":"Transpl Infect Dis"},{"key":"10480_CR26","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1093\/jac\/dkae082","volume":"79","author":"TY Wu","year":"2024","unstructured":"Wu TY, Chen PY, Wang JT, Liu WD, Chen YC, Chang SC. Suboptimal response to combination therapy with tixagevimab\/cilgavimab and remdesivir for persistent SARS-CoV-2 infections in immunocompromised patients. J Antimicrob Chemother. 2024;79:1196\u2013200.","journal-title":"J Antimicrob Chemother"},{"key":"10480_CR27","doi-asserted-by":"publisher","first-page":"e14252","DOI":"10.1111\/tid.14252","volume":"26","author":"A Visentin","year":"2024","unstructured":"Visentin A, Pickavance E, San-Juan R, Grossi PA, Manuel O, Aguado JM. Current management of SARS-CoV-2 infection in solid organ transplant recipients: experience derived from an ESGICH-ESOT survey. Transpl Infect Dis. 2024;26:e14252.","journal-title":"Transpl Infect Dis"},{"key":"10480_CR28","unstructured":"Royal College of Physicians. National Early Warning Score (NEWS) 2: SStandardisingthe assessment of acute-illness severity in the NHS. Updated report of a working party, RCP, London. 2017. Available at: https:\/\/www.rcp.ac.uk\/media\/a4ibkkbf\/news2-final-report_0_0.pdf (accessed Dec 2024)."},{"key":"10480_CR29","unstructured":"ISARIC 4\u00a0C Mortality Score. Available at: https:\/\/isaric4c.net\/risk\/4c\/ (accessed Dec 2024)."},{"key":"10480_CR30","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1001\/jamainternmed.2020.2033","volume":"180","author":"W Liang","year":"2020","unstructured":"Liang W, Liang H, Ou L, et al. Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalised patients with COVID-19. JAMA Intern Med. 2020;180:1081\u20139.","journal-title":"JAMA Intern Med"},{"key":"10480_CR31","doi-asserted-by":"publisher","first-page":"857573","DOI":"10.3389\/fimmu.2022.857573","volume":"13","author":"D Battaglini","year":"2022","unstructured":"Battaglini D, Lopes-Pacheco M, Castro-Faria-Neto HC, Pelosi P, Rocco PRM. Laboratory biomarkers for diagnosis and prognosis in COVID-19. Front Immunol. 2022;13:857573.","journal-title":"Front Immunol"},{"key":"10480_CR32","doi-asserted-by":"publisher","first-page":"e14596","DOI":"10.1111\/ijcp.14596","volume":"75","author":"JR Ulloque-Badaracco","year":"2021","unstructured":"Ulloque-Badaracco JR, Ivan Salas-Tello W, Al-Kassab-C\u00f3rdova A, et al. Prognostic value of neutrophil-to-lymphocyte ratio in COVID-19 patients: a systematic review and meta-analysis. Int J Clin Pract. 2021;75:e14596.","journal-title":"Int J Clin Pract"},{"key":"10480_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0256744","volume":"16","author":"A Poudel","year":"2021","unstructured":"Poudel A, Poudel Y, Adhikari A, Aryal BB, Dangol D, Bajracharya T, et al. D-dimer as a biomarker for assessment of COVID-19 prognosis: D-dimer levels on admission and its role in predicting disease outcome in hhospitalisedpatients with COVID-19. PLoS ONE. 2021;16:1\u201313.","journal-title":"PLoS ONE"},{"key":"10480_CR34","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1210\/jc.2002-021444","volume":"89","author":"KL Becker","year":"2004","unstructured":"Becker KL, Nyl\u00e9n ES, White JC, M\u00fcller B, Snider RH. Clinical review 167: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab. 2004;89:1512\u201325.","journal-title":"J Clin Endocrinol Metab"},{"key":"10480_CR35","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3390\/medicina57060594","volume":"57","author":"Y Shen","year":"2021","unstructured":"Shen Y, Cheng C, Zheng X, et al. Elevated procalcitonin is positively associated with the severity of COVID-19: a meta-analysis based on 10 cohort studies. Medicina. 2021;57:594.","journal-title":"Medicina"},{"key":"10480_CR36","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s13054-020-02995-3","volume":"24","author":"M Aziz","year":"2020","unstructured":"Aziz M, Fatima R, Lee-Smith W, Assaly R. The association of low serum albumin level with severe COVID-19: a systematic review and meta-analysis. Crit Care. 2020;24:255.","journal-title":"Crit Care"},{"key":"10480_CR37","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.pccm.2023.08.004","volume":"1","author":"F Lu","year":"2023","unstructured":"Lu F, Chen R, Xu K, et al. Liver dysfunction on admission worsens clinical manifestations and outcomes of coronavirus disease 2019. Chin Med J Pulm Crit Care Med. 2023;1:181\u20137.","journal-title":"Chin Med J Pulm Crit Care Med"},{"key":"10480_CR38","first-page":"70","volume":"1","author":"L Xu","year":"2024","unstructured":"Xu L, Ying Y, Xie J, et al. Contributing factors affecting the length of hospital stay among febrile patients with Omicron reported in Suzhou. Clin Lab. 2024;1:70.","journal-title":"Clin Lab"},{"key":"10480_CR39","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jinf.2020.05.046","volume":"81","author":"L Lansbury","year":"2020","unstructured":"Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020;81:266\u201375.","journal-title":"J Infect"},{"key":"10480_CR40","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41422-023-00821-3","volume":"33","author":"H Fan","year":"2023","unstructured":"Fan H, Zhou L, Lv J, et al. Bacterial coinfections contribute to severe COVID-19 in winter. Cell Res. 2023;33:562\u20134.","journal-title":"Cell Res"},{"key":"10480_CR41","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jgar.2024.04.007","volume":"38","author":"Y Gan","year":"2024","unstructured":"Gan Y, Zhang G, Sun H, Lyu X. Clinical characteristics and risk factors for bacterial co-infections in COVID-19 patients: a retrospective study. J Glob Antimicrob Resist. 2024;38:6\u201311.","journal-title":"J Glob Antimicrob Resist"},{"key":"10480_CR42","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.tim.2021.03.018","volume":"29","author":"LF Westblade","year":"2021","unstructured":"Westblade LF, Simon MS, Satlin MJ. Bacterial coinfections in Coronavirus Disease 2019. Trends Microbiol. 2021;29:930\u201341.","journal-title":"Trends Microbiol"},{"key":"10480_CR43","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jhin.2021.04.023","volume":"113","author":"V Bordino","year":"2021","unstructured":"Bordino V, Vicentini C, D\u2019Ambrosio A, Quattrocolo F, Collaborating G, Zotti CM. Burden of healthcare-associated infections in Italy: incidence, attributable mortality and disability-adjusted life years (DALYs) from a nationwide study, 2016. J Hosp Infect. 2021;113:164\u201371.","journal-title":"J Hosp Infect"},{"key":"10480_CR44","doi-asserted-by":"publisher","first-page":"e238059","DOI":"10.1001\/jamanetworkopen.2023.8059","volume":"6","author":"KE Sands","year":"2023","unstructured":"Sands KE, Blanchard EJ, Fraker S, Korwek K, Cuffe M. Health care-associated infections among hospitalised patients with COVID-19, March 2020-March 2022. JAMA Netw Open. 2023;6:e238059.","journal-title":"JAMA Netw Open"},{"key":"10480_CR45","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13054-023-04312-0","volume":"27","author":"MJ Patton","year":"2023","unstructured":"Patton MJ, Orihuela CJ, Harrod KS, et al. COVID-19 bacteremic co-infection is a major risk factor for mortality, ICU admission, and mechanical ventilation. Crit Care. 2023;27:34.","journal-title":"Crit Care"},{"key":"10480_CR46","doi-asserted-by":"publisher","first-page":"e234","DOI":"10.1093\/cid\/ciac501","volume":"76","author":"T Brosh-Nissimov","year":"2023","unstructured":"Brosh-Nissimov T, Hussein K, Wiener-Well Y, et al. HHospitalisedpatients with severe Coronavirus Disease 2019 during the Omicron wave in Israel: benefits of a fourth vaccine dose. Clin Infect Dis. 2023;76:e234\u20139.","journal-title":"Clin Infect Dis"},{"key":"10480_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14760584.2023.2143347","volume":"22","author":"R Solante","year":"2023","unstructured":"Solante R, Alvarez-Moreno C, Burhan E, et al. Expert review of global real-world data on COVID-19 vaccine booster effectiveness and safety during the omicron-dominant phase of the pandemic. Expert Rev Vaccines. 2023;22:1\u201316.","journal-title":"Expert Rev Vaccines"},{"key":"10480_CR48","doi-asserted-by":"publisher","first-page":"e232598","DOI":"10.1001\/jamanetworkopen.2023.2598","volume":"6","author":"R Link-Gelles","year":"2023","unstructured":"Link-Gelles R, Levy ME, Natarajan K, et al. Estimation of COVID-19 mRNA vaccine effectiveness and COVID-19 illness and severity by vaccination status during Omicron BA.4 and BA.5 sublineage periods. JAMA Netw Open. 2023;6:e232598.","journal-title":"JAMA Netw Open"},{"key":"10480_CR49","doi-asserted-by":"publisher","first-page":"e70027","DOI":"10.1111\/irv.70027","volume":"18","author":"J DeCuir","year":"2024","unstructured":"DeCuir J, Surie D, Zhu Y, et al. Effectiveness of original monovalent and bivalent COVID-19 vaccines against COVID-19-associated hospitalisation and severe in-hospital outcomes among adults in the United States, September 2022-August 2023. Influenza Other Respir Viruses. 2024;18:e70027.","journal-title":"Influenza Other Respir Viruses"},{"key":"10480_CR50","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1007\/s44197-024-00298-2","volume":"14","author":"\u00c1 Serrano-Ortiz","year":"2024","unstructured":"Serrano-Ortiz \u00c1, Romero-Cabrera JL, Monserrat Villatoro J, et al. Assessing COVID-19 vaccine effectiveness and risk factors for severe outcomes through machine learning techniques: a real-world data study in Andalusia, Spain. J Epidemiol Glob Health. 2024;14:1504\u201317.","journal-title":"J Epidemiol Glob Health"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10480-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-10480-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10480-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T19:54:06Z","timestamp":1738007646000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-10480-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,27]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10480"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-10480-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,27]]},"assertion":[{"value":"1 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Fondazione PTV, University of Rome Tor Vergata (register number 164\/20). The Ethics Committee waived the requirement for informed consent based on the retrospective, observational nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"130"}}